iRGDpeptidesequence The field of peptide research has seen significant advancements with the development of cyclic RGD peptides. These unique molecules, characterized by their specific RGD sequence arranged in a ring structure, have garnered considerable attention for their potent interactions with integrin receptors. This article delves into the intricacies of RGD cyclic peptides, exploring their synthesis, properties, and diverse applications, particularly in the realms of cancer research, drug delivery, and tissue engineering.
At its core, the RGD sequence (Arginine-Glycine-Aspartic acid) is a critical peptide motif responsible for cell adhesion to the extracellular matrix (ECM). This tripeptide motif is found across various species and plays a pivotal role in numerous biological processes. However, linear RGD peptides often suffer from limitations such as poor stability and rapid degradation in vivo. This is where the innovation of cyclic peptides comes into play. By forming a closed loop, cyclic RGD peptides exhibit enhanced stability, improved binding affinity, and greater selectivity for specific integrin receptors compared to their linear counterparts.
Research has demonstrated that cyclic RGD peptides commonly improve the binding properties of RGD peptides.2024年7月22日—RGD4C: Acyclic peptidewith the sequence CDCRGDCFC, known for its high affinity for αvβ3 integrins, which are overexpressed in tumor ... For instance, studies have shown that cyclic hexapeptides like [GRGDFL], [ARGDFV], and [GRGDFV] were significantly more inhibitory than the linear GRGDS peptide in solid-phase assaysUS9073974B2 - RGD-containing cyclic peptides. The structural rigidity imparted by the cyclic conformation allows for a more precise presentation of the RGD motif, leading to stronger and more specific interactions with integrin receptors such as αvβ3 integrin and αvβ5 integrin. These receptors are often overexpressed on cancer cells and in tumor vasculature, making them prime targets for therapeutic interventionsThis is acyclicRGDfC sequence, an integrin avb3-affinepeptide. Specifications. Chemistry. Sequence one letter code. Cyclo(-RGDfC). Sequence three letter code..
The synthesis of RGD cyclic peptides has been approached through various methodologies. One notable method involves using a click chemistry approach to prepare new cyclic RGD peptidesOptimization of RGD-Containing Cyclic Peptides against αvβ3 .... Another common strategy is solid-phase peptide synthesis, which allows for the controlled assembly of the peptide chain before cyclization. For example, the linear RGDfV peptide can be synthesized using solid-phase peptide synthesis, and subsequently cyclizedThe well-known head-to-tailcyclic peptidecyclo(RGDfV), although has high binding affinity and specificity against αvβ3 integrin, lacks a handle for attachment .... Some approaches also involve incorporating specific amino acids like cysteine to facilitate disulfide bond formation, creating a stable cyclic structureCyclo(Arg-Gly-Asp-D-Phe-Cys) (Cyclo RGDfC), acyclic RGD peptidewhich has high affinity to αvβ3, can disrupt cell integrin interactions.. Patents describe RGD-containing cyclic peptides linked via a disulfide bond, often with terminal cysteines in the D configuration for enhanced stability作者:A Müller·1997·被引用次数:27—Summary. The solid phase synthesis ofcyclic RGD-peptidescontaining β-amino acids according to two different protocols is described. The second strategy allows .... Furthermore, advancements include the synthesis of cyclic RGD-peptides containing β-amino acids, offering alternative structural frameworksSelective recognition of cyclic RGD peptides of NMR ....
The applications of RGD cyclic peptides are vast and continue to expand. In cancer research, these peptides serve as valuable tools for targeting cancer cells and tumor vasculature, thereby improving drug delivery efficiency作者:R Haubner·1996·被引用次数:845—The design of low-molecular-mass α V β 3 antagonists by “spatial screening” led to the highly activepeptidesc(RGDFV) and c(RGDFV).. RGD peptides can be utilized to specifically target cancer cells by engaging with integrins. For example, the RGD peptide motif is a key component in developing fluorescence imaging agents for diagnostic purposes. iRGD peptides, a class of 9-amino acid cyclic peptides containing an RGD sequence, have shown promise in tumor targeting and can undergo internalization. CEND-1, also known as iRGD, is a bifunctional cyclic peptide that binds to the RGD motif and the integrin αV receptor to target tumorsSolution Structure of a Cyclic RGD Peptide That Inhibits ....
The development of cyclic RGD peptide-based therapeutics is a major focus. Cyclo(Arg-Gly-Asp-D-Phe-Cys) (Cyclo RGDfC) is a cyclic RGD peptide with high affinity to αvβ3, capable of disrupting cell integrin interactions. Cyclic RGDfC is an integrin αvβ3-affine peptide and a cyclic RGD tumor-targeting peptideCEND-1, also known as iRGD, is a bifunctionalcyclic peptidethat binds to theRGDmotif and the integrin αV receptor to target tumors. Combinded with .... N-Methylated Cyclic RGD Peptides have been developed as highly active and selective ligands for the αvβ3 integrin receptor. Studies have explored the potential of radiolabeled cyclic RGD peptides as radiotracers for the diagnosis of tumors or thrombosis, depending on their selectivity.
Beyond cancer, RGD cyclic peptides are finding applications in tissue engineering.CyAL-5 cRGD is afluorescence imaging agentcomprising a potentcyclic RGD peptide, c(RGDfK) designed to target integrins and a CyAL-5 dye with emission at 658 ... Their ability to promote cell adhesion makes them valuable for developing biomaterials that support tissue regeneration. Research has investigated why cyclic-RGD has been used for cell adhesion in tissue engineering studies, highlighting its advantages over linear RGD peptides.
The specificity of these peptides for certain integrins is crucial. For instance, cyclo(RGDfV), while possessing high binding affinity and specificity against αvβ3 integrin, may lack a handle for attachment in certain applications.Optimization of RGD-Containing Cyclic Peptides against αvβ3 ... This has led to the development of cyclic peptides with modifications to facilitate conjugation. The chemical formula for cyclic RGD is C24H36N8O9S, as identified in databases like PubChem.作者:E Koivunen·1995·被引用次数:744—...RGD-containing phage sequences but favored different ring sizes and different flanking residues around theRGDmotif. Acyclic peptide...
The field continues to evolve with the creation of novel cyclic peptide designs. For example, CyAL-5 cRGD is a fluorescence imaging agent comprising a potent cyclic RGD peptide, c(RGDfK), designed to target integrins, coupled with a CyAL-5 dye.This is acyclicRGDfC sequence, an integrin avb3-affinepeptide. Specifications. Chemistry. Sequence one letter code. Cyclo(-RGDfC). Sequence three letter code. Efforts are also underway to develop photoactivatable caged cyclic RGD peptides for triggering cell attachment with spatiotemporal control.
In summary, RGD cyclic peptides represent a significant advancement in peptide chemistry and its applications. Their enhanced stability, potent binding affinity, and remarkable specificity for integrin receptors have opened new avenues in drug discovery, diagnostics, and regenerative medicine. As research progresses, we can expect even more innovative uses for these powerful cyclic peptides.A Cyclo-RGD Peptide for the Preparation of Tumor Mimics
Join the newsletter to receive news, updates, new products and freebies in your inbox.